Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891.
about
Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute LeukemiaIdarubicin plus behenoyl cytarabine and 6-thioguanine compares favorably with idarubicin plus cytarabine-based regimen for children with previously untreated acute myeloid leukemia: 10-year retrospective, multicenter study in KoreaHigh level of miR-196b at newly diagnosed pediatric acute myeloid leukemia predicts a poor outcomeHematopoietic stem cell transplantation for leukemiaNovel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group.Biology, risk stratification, and therapy of pediatric acute leukemias: an update.Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international studySurvival of Mexican children with acute myeloid leukaemia who received early intensification chemotherapy and an autologous transplantGlobal characteristics of childhood acute promyelocytic leukemia.FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia.Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia.A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group.Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapyIdentification and characterization of novel AML1-ETO fusion transcripts in pediatric t(8;21) acute myeloid leukemia: a report from the Children's Oncology Group.Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems databaseThe heterogeneity of pediatric MLL-rearranged acute myeloid leukemia.Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.A critical review of which children with acute myeloid leukaemia need stem cell procedures.Autocrine motility factor receptor promotes the proliferation of human acute monocytic leukemia THP-1 cells.Effect of RNAi-induced down regulation of nuclear factor kappa-B p65 on acute monocytic leukemia THP-1 cells in vitro and vivo.Acute Myeloid Leukemia in Children: Experience from Tertiary Cancer Centre in India.Homoharringtonine as a backbone drug for the treatment of newly diagnosed pediatric acute myeloid leukemia: a report from a single institution in China.Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group.Acute Myeloid Leukemia in Adolescents and Young Adults Treated in Pediatric and Adult Departments in the Nordic Countries.Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications.No impact of high-dose cytarabine and asparaginase as early intensification with intermediate-risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99-15.Prognosis of patients with t(8;16)(p11;p13) acute myeloid leukemia.Improved survival outcome of childhood acute myeloid leukemia with intensified chemotherapy in Chinese children.Treatment of acute myeloid leukemia in children: experience from a tertiary care hematology centre in India.Long-term outcome of childhood acute myeloid leukemia in a developing country: experience from a children's hospital in China.Pediatric standard-risk AML with fully matched sibling donors: to transplant in first CR or not?Presenting features and imaging in childhood acute myeloid leukemia with central nervous system involvement.Acute myeloid leukemia in children: Current status and future directions.A comparison of the outcomes of children with acute myelogenous leukemia in either first or second complete remission (CR1 vs CR2) following allogeneic hematopoietic stem cell transplantation at a single transplant center.Similar outcomes of allogeneic hematopoietic cell transplantation from unrelated donor and umbilical cord blood vs. sibling donor for pediatric acute myeloid leukemia: Multicenter experience in China.Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia.
P2860
Q26781328-E96F9AE5-7AA2-442A-83D6-D2E84530950EQ33565514-5F1AF5ED-EF54-4C05-8A44-EEF1745AC908Q33667247-D2CC7ADE-837C-44E1-A58B-1A1C62363D8CQ34034180-1C9A5989-3252-42CA-821A-E3A10F3046E5Q34080807-C30211E8-8B6C-4E1F-942E-7FAE898C5571Q34307972-E4C85526-3E83-4EF1-BB59-F2433731FBDCQ34764504-6FC80764-7DDF-48C0-805B-FC36C1C91306Q35127974-3EE4AB4E-4FDA-401B-B2EC-76E5C45B6FBFQ35189037-BC26D6FE-A5A6-4DAB-9802-B16408DA1CFAQ35231673-5646AAF3-86EE-4D00-BD58-0F50F8520E1BQ35849209-3B691B04-A41C-4247-A902-63A77F666D91Q36407162-9C7A62F2-45B9-4BC7-94E7-6BC61CBB590CQ36430103-858E87FD-C46A-48FF-9551-0A9A7003AB3BQ36915159-6BC3D6BE-91A7-4E30-AB54-B7FD32E59FE8Q36984687-2AD0AF65-C3CF-483A-82F2-1ECEE461DFBCQ37121665-07EBD0C7-9D6F-46AC-BD13-F052320A6329Q37149438-A01CBBFA-1132-4363-AC55-14BE6C7C7BB9Q37569911-015789D6-6FA2-48DB-BC84-5ABE429C5C0BQ37874929-5E68FB64-6227-4345-BC03-4D60F7922C85Q38155455-8614FE07-65B9-4EE9-B753-440C43DF79CDQ38196743-5A61D1A3-9FEE-4AD4-9931-FEEE2ABE92C6Q38205864-7B49BD3A-838E-4A48-9E1F-DFFA87A04529Q38857427-092EBDBB-7855-4C3A-B3BB-E32DAFDBBC07Q39477447-50F0BC94-EF3C-4549-A1F9-E6BAC99B4034Q39589791-22F034F4-4507-4474-B5F1-90F24ECF9104Q39758498-1F588768-B6D6-405C-9613-666A656A2612Q40446750-9C1E7161-C22C-4F3A-94FF-5B078DF1DCC5Q40634949-D4C5D8F1-F8DC-41A0-A4B0-E34793F0DF54Q41973082-142E127C-9FBA-40EF-9B8A-5158706F9DF5Q42242801-0C6F2E78-17BE-415E-9F1A-B8A6FACFCB9FQ43574379-101144D8-F0FD-4B76-832F-103528C780ACQ43928924-F3AC6E06-5256-4035-A523-A2D752124B4FQ44126009-4B6F9520-F863-467D-BC3E-3723B97E6D24Q44659117-21CF7C7E-0EBF-422F-BDA5-5BF756056A87Q45165836-06A7EA5C-5703-4B72-8300-42E51E046687Q52787089-BFD8FDDE-E7F3-49A4-82AA-F7609E763A93Q52897332-93542668-313C-45D4-A0D2-0C0D3D0253AFQ53499124-08E86FFC-53F7-4B24-B0E5-88B92E56FB85Q53533468-27FC5FB7-7DE0-41C5-9608-C2822B526AD2Q54569630-484F1BA4-1F4F-4D07-B77F-C7435CD8CADD
P2860
Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Long-term results of children ...... CCG 251, CCG 213 and CCG 2891.
@en
type
label
Long-term results of children ...... CCG 251, CCG 213 and CCG 2891.
@en
prefLabel
Long-term results of children ...... CCG 251, CCG 213 and CCG 2891.
@en
P2093
P2860
P356
P1433
P1476
Long-term results of children ...... CCG 251, CCG 213 and CCG 2891.
@en
P2093
Children's Cancer Group
R B Gerbing
R J Arceci
T A Alonzo
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403925
P577
2005-12-01T00:00:00Z
P5875
P6179
1011198838